Shandong Lukang Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000P61
CNY
8.47
-2.63 (-23.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,616.45
1,141.77
1,470.36
1,465.15
1,661.29
1,550.18
1,387.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,616.45
1,141.77
1,470.36
1,465.15
1,661.29
1,550.18
1,387.48
Raw Material Cost
1,271.92
899.94
1,202.35
1,144.49
1,354.05
1,116.10
1,130.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.50
16.52
15.83
16.92
16.51
18.22
20.39
Selling and Distribution Expenses
177.17
178.92
142.21
141.77
180.23
198.26
148.40
Other Expenses
5.08
5.31
5.82
4.43
4.42
6.76
3.57
Total Expenditure (Excl Depreciation)
1,513.41
1,148.44
1,418.59
1,347.48
1,595.00
1,400.19
1,334.98
Operating Profit (PBDIT) excl Other Income
103
-6.7
51.8
117.69999999999999
66.3
150
52.5
Other Income
4.28
13.36
26.31
18.35
21.24
2.04
22.28
Operating Profit (PBDIT)
81.44
112.01
178.78
181.03
210.10
186.16
178.23
Interest
13.50
16.52
15.83
16.92
16.51
18.22
20.39
Exceptional Items
0.00
0.00
0.00
-0.07
0.00
-0.02
0.20
Gross Profit (PBDT)
344.52
241.83
268.00
320.66
307.23
434.08
257.02
Depreciation
0.00
118.51
118.51
106.26
106.26
104.59
104.59
Profit Before Tax
67.95
-23.02
44.44
57.78
87.33
63.33
53.45
Tax
10.20
9.58
7.43
28.60
3.68
10.14
1.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
53.25
-28.89
34.36
28.24
78.60
47.56
47.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
53.25
-28.89
34.36
28.24
78.60
47.56
47.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.28
-5.82
1.61
0.06
3.75
3.87
3.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
56.53
-34.71
35.97
28.30
82.35
51.43
50.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,167.57
5,114.66
3,957.02
3,944.15
3,995.58
3,918.19
3,893.47
Earnings per share (EPS)
0.05
-0.03
0.04
0.03
0.09
0.05
0.05
Diluted Earnings per share
0.05
-0.03
0.04
0.03
0.09
0.05
0.05
Operating Profit Margin (Excl OI)
4.77%
-1.74%
2.31%
3.85%
4.97%
5.13%
3.7%
Gross Profit Margin
4.2%
8.36%
11.08%
11.2%
11.65%
10.83%
11.39%
PAT Margin
3.29%
-2.53%
2.34%
1.93%
4.73%
3.07%
3.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 41.57% vs -22.35% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 262.82% vs -196.39% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -21.78% vs -35.28% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -18.18% vs 4.43% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Shandong Lukang Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,616.45
0
1,616.45
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,616.45
0
1,616.45
Raw Material Cost
1,271.92
0
1,271.92
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.50
0
13.50
Selling and Distribution Expenses
177.17
0
177.17
Other Expenses
5.08
0.00
5.08
Total Expenditure (Excl Depreciation)
1,513.41
0
1,513.41
Operating Profit (PBDIT) excl Other Income
103.03
0.00
103.03
Other Income
4.28
0
4.28
Operating Profit (PBDIT)
81.44
0
81.44
Interest
13.50
0
13.50
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
344.52
0
344.52
Depreciation
0.00
0
0.00
Profit Before Tax
67.95
0
67.95
Tax
10.20
0
10.20
Provisions and contingencies
0
0
0.00
Profit After Tax
53.25
0
53.25
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
53.25
0
53.25
Share in Profit of Associates
0
0
0.00
Minority Interest
3.28
0
3.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
56.53
0
56.53
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,167.57
0
5,167.57
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
4.77%
0%
0.00
4.77%
Gross Profit Margin
4.20%
0%
0.00
4.20%
PAT Margin
3.29%
0%
0.00
3.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 161.64 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 41.57% vs -22.35% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -2.70% vs -7.64% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.65 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 262.82% vs -196.39% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -31.35% vs 15.92% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.72 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -21.78% vs -35.28% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -59.13% vs 11.71% in Mar 2025

Quarterly - Interest
Interest 1.35 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -18.18% vs 4.43% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -18.18% vs -13.16% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.77%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025